168 related articles for article (PubMed ID: 11220886)
1. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
Elliot HL
Ter Arkh; 2000; 72(10):78-82. PubMed ID: 11220886
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibition in chronic renal failure and in the treatment of diabetic nephropathy: focus on spirapril.
Jardine AG; Elliott HL
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S31-4. PubMed ID: 10499562
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
Haufe CC; Sierakowski B; Jansa U; Stein G
Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
[TBL] [Abstract][Full Text] [Related]
5. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
6. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
7. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
Elliott HL
Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
[TBL] [Abstract][Full Text] [Related]
9. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
10. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
11. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
Sato A; Hayashi K; Saruta T
Am J Hypertens; 2005 Jan; 18(1):44-9. PubMed ID: 15691616
[TBL] [Abstract][Full Text] [Related]
12. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Deedwania PC
Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
[TBL] [Abstract][Full Text] [Related]
14. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
19. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
20. Spirapril in chronic renal failure.
Stein G; Sierakowski B; Jansa U; Haufe CC
Blood Press Suppl; 1994; 2():54-60. PubMed ID: 8061847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
